Skip to main content

Main navigation

  • Home
  • About
    • About Us
    • Our Partners
    • Our People
  • Projects
    • Adverse Events of Special Interest in NZ Primary Care
    • COVID-19-SENT-[Africa-8]
    • Epidemiological assessment of adverse events following measles, mumps, and rubella (MMR) vaccination
    • Genomics of COVID-19 Vaccine-Induced Adverse Events
    • Global COVID Vaccine Safety (GCoVS)
    • SAFE [NZ background rates for AESI 2008–2019]
  • Resources
    • Blogs
    • Data Dashboard
    • News
    • Newsletter
    • Publications
    • Useful Links
    • Videos and Webinars
  • Contact
Global Vaccine Data Network Logo
Collaborating on vaccine safety and effectiveness studies using health data from around the world.
  1. Home
  2. News

GVDN Mobile Menu

  • Home
  • About
    • About Us
    • Our Partners
    • Our People
  • Projects
    • Adverse Events of Special Interest in NZ Primary Care
    • COVID-19-SENT-[Africa-8]
    • Epidemiological assessment of adverse events following measles, mumps, and rubella (MMR) vaccination
    • Genomics of COVID-19 Vaccine-Induced Adverse Events
    • Global COVID Vaccine Safety (GCoVS)
    • SAFE [NZ background rates for AESI 2008–2019]
  • Resources
    • Blogs
    • Data Dashboard
    • News
    • Newsletter
    • Publications
    • Useful Links
    • Videos and Webinars
  • Contact
News Banner

News

News item
12 August 2022
Responding to the need: GVDN includes smallpox vaccine in global vaccine safety surveillance
Banner
20 April 2022
GVDN™ partners in Finland and Denmark review post-mRNA COVID vaccination myocarditis and pericarditis in 23 million Nordic residents
Banner
13 April 2022
Pandemic propels global effort to study rare vaccine side effects
  • Home
  • Contact
  • Facebook
  • Waipapa Taumata Rau, University of Auckland
  • Accessibility
  • Copyright
  • Privacy
  • Disclaimer